Suppression of polypogenesis in a new mouse strain with a truncated ApC(Δ474) by a novel COX-2 inhibitor, JTE-522

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 953-958

  Sasai, Hitoshi ^a   Masaki, Michiko ^a   Wakitani, Korekiyo ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; TILMACOXIB;

ADENOMATOUS POLYP; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; COLON CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; GENE MUTATION; GENE TARGETING; INTESTINE TUMOR; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BENZENESULFONATES; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; GENES, APC; GENOTYPE; ISOENZYMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTATION; OXAZOLES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034020480     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
2. Moser, A.R., Pitot, H.C. and Dove, W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
3. Spirio, L., Olschwang, S., Groden, J., Robertson, M., Samowitz, W., Joslyn, G., Gelbert, L., Thliveris, A., Carlson, M., Otterud, B., Lynch, H., Watson, P., Lynch, P., Laurent-Puig, P., Burt, R., Hughes, J.P., Thomas, G., Leppert, M. and White, R. (1993) Alleles of the APC gene: an attenuated form of familial polyposis. Cell, 75, 951-957.
4. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
5. Rao, C.V., Rivernson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B.S. (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472.
6. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
7. Matsushita, M., Masaki, M., Yagi, Y., Tanaka, T. and Wakitani, K. (1997) Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm. Res., 46, 461-466.
8. Wakitani, K., Nanayama, T., Masaki, M. and Matsushita, M. (1998) Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Jpn. J. Pharmacol., 78, 365-371.
9. Masaki, M., Matsushita, M. and Wakitani, K. (1998) Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats. Inflamm. Res., 47, 187-192.
10. Soravia, C., Berk, T., Madlensky, L., Mitri, A., Cheng, H., Gallinger, S., Cohen, Z. and Bapat, B. (1998) Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am. J. Hum. Genet., 62, 1290-1301.
11. Nagase, H., Miyoshi, Y., Horii, A., Aoki, T., Ogawa, M., Utsunomiya, J., Baba, S., Sasazuki, T. and Nakamura, Y. (1992) Correlation between the location of germ-line mutations in APC gene and the number of colorectal polyps in familial polyposis patients. Cancer Res., 52, 4055-4057.
12. Friedl, W., Meuschel, S., Caspari, R., Lamberti, C., Krieger, S., Sengteller, M. and Propping, P. (1996) Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein. Hum. Genet., 97, 579-584.
13. Su, L.K., Johnson, K.A., Smith, K.J., Hill, D.E., Vogelstein, B. and Kinzler, K.W. (1993) Association between wild-type and mutant APC gene products. Cancer Res., 53, 2728-2731.
14. Oshima, M., Oshima, H., Kobayashi, M., Tsutsumi, M. and Taketo, M.M. (1995) Evidence against dominant negative mechanisms of intestinal polyp formation by APC gene mutations. Cancer Res., 55, 2719-2722.
15. Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M., Khan, P.M. and Kucherlapati, R. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl Acad. Sci. USA, 91, 8969-8973.
16. Ito, M., Miura, S. and Noda, T. (1995) Mouse model for familial polyposis coli and APC gene. Tanpakshitu Kakusan Koso, 40, 2035-2044.
17. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo, M. (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl Acad. Sci. USA, 92, 4482-4486.
18. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl Acad. Sci. USA, 90, 8977-8981.
19. Eberhart, G.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and DuBois, R.N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
20. DuBois, R.N., Radhika, A., Reddy, B.S. and Entingh, A.J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110, 1259-1262.
21. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sugimura, T. and Wakabayashi, K. (1997) Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res., 88, 1117-1120.
22. Fukutake, M., Nakatsugi, S., Isoi, T., Takahashi, M., Ohta, T., Mamiya, S., Taniguchi, Y., Sato, H., Fukuda, K., Sugimura, T. and Wakabayashi, K. (1998) Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis, 19, 1939-1942.
23. Kawamori, T., Rao, C.V., Seibert, K. and Reddy, B.S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
24. Fischer, S.M., Lo, H., Gordon, G.B., Seibert, K., Kelloff, G., Lubet, R.A. and Conti, C.J. (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 25, 231-240.
25. Molina, M.A., Sitja-Arnau, M., Lemoine, M.G., Frazier, M.L. and Sinicrope, F.A. (1999) Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res., 59, 4356-4362.
26. Yoshimi, N., Shimizu, M., Matsunaga, K., Yamada, Y., Fujii, K., Hara, A. and Mori, H. (1999) Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Jpn. J. Cancer Res., 90, 406-412.
27. Tsujii, M. and DuBois, R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
28. Chan, T.A., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl Acad. Sci. USA, 95, 681-686.
29. Min-induced intestinal neoplasia. Cell, 81, 957-966.
30. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J.A. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med., 328, 1313-1316.